|
|
Article: PerkinElmer Receives FDA Clearance for World's First Tandem Mass Spectrometry Newborn Screening System.
- Article from:
- Business Wire
- Article date:
- August 26, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON -- PerkinElmer, Inc. (NYSE: PKI):
--Kit Screens for Metabolic Disorders; Enables Early Detection and Intervention
--Analyzes More Than 40 Disease Markers with a Single Blood Sample
PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions, today announced that it has received clearance from the U.S. Food and Drug Administration for its NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit. PerkinElmer now has the world's first kit cleared by the FDA for use in the global standardization of Metabolic Screening with Tandem Mass Spectrometry.
Newborn screening ...